Event on
The value of CRP point-of-care testing in the fight against antimicrobial resistance
프레젠테이션
-
Prof. Nicholas Francis
(UK)
ChairSafe reduction of antibiotics for acute exacerbations of chronic obstructive pulmonary disease using CRP point-of-care testing: The findings of the PACE Study.
-
Prof. Rogier Hopstaken
(The Netherlands)
SpeakerReduction of antibiotic prescribing at primary care: Evidence of the established role of CRP point-of-care testing.
-
Prof. Ivan Gentile
(Italy)
SpeakerThe fight against antimicrobial resistance in Italy.
제시된 견해와 의견은 저자의 것입니다. 이 웹캐스트에 포함된 콘텐츠는 정보 제공/교육 목적으로만 사용됩니다.
Background
Join our panel of experts from across Europe to learn about the value of C-reactive protein (CRP) point-of-care testing (POCT) to help fight antimicrobial resistance and as an aid to help avoid the misuse of antibiotics. 90% of respiratory tract infections (RTIs) are viral and therefore antibiotics have no clinical benefit. And yet RTIs are one of the most common reasons for unnecessary antibiotic prescribing [1]. The webinar will analyse studies and present front-line experience on the value of CRP POCT told through the eyes of internationally acclaimed healthcare professionals and academics from the UK, the Netherlands and Italy.
제시된 견해와 의견은 저자의 것입니다. 이 웹캐스트에 포함된 콘텐츠는 정보 제공/교육 목적으로만 사용됩니다.
- ↑ CDC. Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19). Update 27. Oct 2020. Downloaded June 2021. https://stacks.cdc.gov/view/cdc/89980
© 2024 애보트. 판권 소유. 참조된 모든 상표는 Abbott 그룹 회사 또는 해당 소유자의 상표입니다. COL-00000